We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Combined Use of MRI and Ultrasound Boosts Market Growth

By HospiMedica International staff writers
Posted on 13 Mar 2012
When combined, magnetic resonance imaging (MRI) and ultrasound imaging becomes more effective, and this trend is among the many factors mentioned by a new market research report for the growth in sales of both modalities.

In healthcare market research publisher Kalorama Information’s (New York, NY, USA) recent report, the firm noted that worldwide revenues for MRI and ultrasound systems grew at 6% and 4%, respectively, between 2010 and 2011. More...


One example of combination usage is in rotator cuff tears. Whereas ultrasound is typically seen as more cost effective, MRI is most frequently used to assess the rotator cuff. When performing a cost utility analysis, utilizing ultrasound as the first medical imaging test for a rotator cuff tear, in addition to a preoperative MRI to identify alternative and concurrent diagnoses, can be a very effective hybrid imaging approach.

“Ultrasound is a cheaper imaging modality, yet MRI can provide more depth,” said Joe Constance, Kalorama’s imaging analyst and the author of the report. “So it’s not a surprise to see ultrasound recommended for the initial medical imaging test and an MRI as a secondary test to find any alternate diagnosis and give the surgeon the needed anatomy.”

Another field where a combination of modalities is used, according to Kalorama, is in breast cancer. A second-look ultrasound of the breast, used in conjunction with MRI, allows radiologists to identify lesions not detected with conventional mammography and first-look ultrasound; in some cases, it allows radiologists to determine whether or not a lesion is malignant or benign. This was underscored in a study performed at the University of Rome La Sapienza (Rome, Italy), which included 182 patients who had mammography, ultrasound, and MRI. It has become accepted among some radiologists.

New research may find new combination uses. An experimental procedure developed by scientists at the University of California, Los Angeles (UCLA; USA) fuses MRI with real-time three-dimensional (3D) ultrasound to obtain biopsy specimens from suspicious areas in the prostate. Patients first received MRI scans of the prostate that evaluated three components in detecting cancer: suspicious contrasts in tissue, abnormal cellular density, and unusual blood flow within the prostate.

Kalorama Information, a division of MarketResearch.com, supplies independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare, as well as custom research services.

Related Links:

Kalorama Information



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Glucose Meter
StatStrip®
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.